Affordable Access

deepdyve-link
Publisher Website

Differences in medication use in the Alzheimer's disease neuroimaging initiative: analysis of baseline characteristics.

Authors
  • Epstein, Noam U
  • Saykin, Andrew J
  • Risacher, Shannon L
  • Gao, Sujuan
  • Farlow, Martin R
Type
Published Article
Journal
Drugs & Aging
Publisher
Springer-Verlag
Publication Date
Aug 01, 2010
Volume
27
Issue
8
Pages
677–686
Identifiers
DOI: 10.2165/11538260-000000000-00000
PMID: 20658795
Source
Medline
License
Unknown

Abstract

AD and MCI participants from the ADNI cohort were being treated with polypharmacy and many were also taking one or more medications with the potential for adverse effects. Off-label use of cholinesterase inhibitors and/or memantine for MCI was common, with more severely affected patients most likely to receive treatment. Differences in the frequency of symptomatic treatment were also observed as a function of age, years of education, gender and disease severity.

Report this publication

Statistics

Seen <100 times